PPARA and diabetes mellitus: For example, we have shown that treatment with the PPARα agonist, gemfibrozil (100 mg/kg/day), is able to attenuate albuminuria, glomerulosclerosis, tubulointerstitial expansion, and collagen IV deposition associated with streptozotocin-induced diabetes (Figure 1) [25].